CAMBRIDGE, Mass., May 2, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Deutsche Bank 37th Annual Health Care Conference in Boston. Marc D. Beer, CEO of Aegerion, is scheduled to present on Monday, May 7, 2012 at 10:40 a.m. ET.
